Cardiokine is a biotechnology and pharmaceutical startup founded in 2003. The company focuses on managing project management, QA, QC, data management, and procurement in the healthcare industry. In its latest funding round in May 2006, Cardiokine secured a significant $50.00M Series B investment. The investment was led by a consortium of prominent investors including Eight Roads Ventures, Advent Venture Partners, HealthCare Ventures, Care Capital, Burrill & Company, CIBC Capital Partners, Fidelity Biosciences, Ontario Teachers' Pension Plan, and Perseus-Soros Biopharmaceutical Fund.
General Information
BounceWatch is an independent company data service, not affiliated with Cardiokine. To contact Cardiokine, visit cardiokine.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Cardiokine compare?
A PDF of Cardiokine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Cardiokine soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Cardiokine
Funding Rounds & Investors (2)
View AllCardiokine Alternatives & Competitors
View All AlternativesOur mission is to save and improve lives by creating well-functioning health supply chains.
Life Science eProcurement
FAQ About Cardiokine
Source: BounceWatch company record for Cardiokine, https://bouncewatch.com/company/cardiokine, updated 27 December 2024. When citing, please name BounceWatch and link this page.